Abcuro, Inc.
Pharmaceutical company · Newton, Massachusetts, United States
Abcuro, Inc. is a pharmaceutical company headquartered in Newton, Massachusetts, United States. Its earliest recorded incorporation is in 2015. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $295,317 in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $80 million sold in a notice filed in 2025.
Abcuro at a glance
What does Abcuro do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $295,317 in total (2019). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $80 million sold (2025).
Frequently asked questions about Abcuro
Where is Abcuro headquartered?
Abcuro, Inc. is headquartered in Newton, Massachusetts, United States.
What does Abcuro do?
Abcuro, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Abcuro founded?
The earliest incorporation on record for Abcuro, Inc. is in 2015, according to public company registers.
Similar companies
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.